Industries > Pharma > Global Interventional Cardiology Market 2017-2027

Global Interventional Cardiology Market 2017-2027

Percutaneous Coronary Intervention (PCI), Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve Implantation (TMVR)

PUBLISHED: 31 January 2017
PAGES: 225
PRODUCT CODE: PHA0165

Clear
WOOCS 2.2.1
SKU: PHA0165 Categories: , ,

The global interventional cardiology market is expected to grow at a CAGR of 11.1% in the first half of the forecast period and CAGR of 16.9% in the second half of the forecast period. The market is expected to grow at a CAGR of 15.0% from 2017 to 2027. The market is estimated at $13,920m in 2021 and $35,537m in 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 225-page report you will receive 111 charts – all unavailable elsewhere.

The 225-page report provides clear detailed insight into the global interventional cardiology market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Global Interventional Cardiology Market 2017-2027

Report Scope

Global Interventional Cardiology Market forecasts from 2017-2027

Percutaneous Coronary Intervention (PCI) submarket forecasts from 2017-2027, further segmented into:
Drug-eluting Stents (DES)
Bare Metal Stents
Bioresorbable Stents

This section also discusses the leading products, competitive landscape, market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for PCI in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.

Transcatheter Aortic Valve Implantation (TAVI/TAVR) from 2017-2027
This section also discusses the market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for TAVI/TAVR in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.

Trans Mitral Valve Implantation (TMVR) submarket forecasts from 2017-2027
This section also discusses the market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for TMVR in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.

• Interventional Cardiology Leading National Market forecasts from 2017-2027 covering the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China, India and the Rest of the World (RoW)

Each country is further segmented into PCI, TAVI and TMVR.

• Assessment of selected leading companies that hold major market shares in the interventional cardiology market

SWOT and STEP analysis of the global interventional cardiology market

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Interventional Cardiology Market. You find data, trends and predictions.

Buy our report today Global Interventional Cardiology Market 2017-2027: Percutaneous Coronary Intervention (PCI), Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve Implantation (TMVR).

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Interventional Cardiology Market 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Interventional Cardiology Market 2017-2027


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories